On November 2, 2023, Ms. Ines Dahne-Steuber tendered her resignation as Chief Operating Officer of Guardant Health, Inc., effective as of November 10, 2023. Ms. Dahne-Steuber will remain employed through December 1, 2023 in order to assist with the transition of her duties.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.88 USD | -0.59% | -2.30% | +6.77% |
Jun. 28 | Top Premarket Gainers | MT |
Jun. 28 | Guggenheim Upgrades Guardant Health to Buy From Neutral, Price Target at $36 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.77% | 3.53B | |
-42.89% | 7.8B | |
-1.35% | 2.24B | |
-27.06% | 1.84B | |
-21.23% | 1.66B | |
+9.31% | 951M | |
+29.42% | 811M | |
-12.66% | 670M | |
-26.12% | 533M | |
+1.19% | 296M |
- Stock Market
- Equities
- GH Stock
- News Guardant Health, Inc.
- Guardant Health, Inc. Announces Resignation of Ines Dahne-Steuber as Chief Operating Officer, Effective as of November 10, 2023